Omega-3 Fatty Acids to Combat Sarcopenia
NCT02103842 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 24
Last updated 2015-12-24
Summary
The purpose of this study is to determine how omega-3 fatty acids influence muscle protein metabolism and mitochondrial physiology in the context of human aging.
Conditions
Interventions
- DRUG
-
Omega-3 fatty acids
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Ian R Lanza, PhD · Mayo Clinic
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2014-03-31
- Primary Completion
- 2015-07-31
- Completion
- 2015-07-31
Countries
- United States
Study Locations
More Related Trials
-
Omega-3 Fatty Acid Supplementation in Older Adults
NCT01666392 ·Status: WITHDRAWN ·Phase: NA
-
Fish Oil Supplementation, Resting Energy Expenditure, Skeletal Muscle Membrane Composition and Metabolism in Elderly Subjects.
NCT02338401 ·Status: UNKNOWN ·Phase: NA
-
Enhancing Adaptations to Exercise
NCT03350906 ·Status: COMPLETED ·Phase: PHASE3
-
Short Term Omega-3 Supplementation on Performance
NCT02014233 ·Status: COMPLETED ·Phase: NA
-
Effect of Combined Fatty Acid Supplementation and Eccentric Exercise Training on Exercise Performance
NCT03259412 ·Status: COMPLETED ·Phase: NA
-
Comparison of EPA and DHA-Rich Fish Oils on Lipoprotein Metabolism In Adults
NCT02514070 ·Status: COMPLETED ·Phase: PHASE2
-
The Effects of Omega-3 Fatty Acids on Metabolic Syndrome
NCT00350194 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
S0927:Omega3-Fatty Acid Supp in Treating Muscle&Bone Pain&Stiffness in Pts W/Stg I,II,III Brst Canc Rec'v Hormone Thpy
NCT01385137 ·Status: COMPLETED ·Phase: PHASE3
-
Vitamin D and Omega-3 Inhibit Metabolic Syndrome
NCT01326442 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect of Omega-3 Supplementation on Muscle Functioning, Inflammation and Muscle Signaling
NCT03986307 ·Status: COMPLETED ·Phase: NA
-
Omega-3 Fatty Acids and Insulin Sensitivity
NCT01686568 ·Status: COMPLETED ·Phase: PHASE3
-
n3 PUFA and Muscle-disuse Atrophy in Young Women
NCT03059836 ·Status: COMPLETED ·Phase: NA
-
Impact of Fish Oil Dose on Tissue Content and Function
NCT04772040 ·Status: COMPLETED ·Phase: NA
-
Impact of an Optimized Formulation of Omega 3 on the Composition of Atheromatous Plaques in Patients Requiring Carotid Endarterectomy
NCT02582710 ·Status: UNKNOWN ·Phase: PHASE3
-
Effects of Omega-3 Docosapentaenoic Acid on Lipids and Other Risk Factors for Cardiovascular Disease
NCT04088240 ·Status: TERMINATED ·Phase: NA
-
Effects of 12 Weeks of Omega 3 Supplementation on Resting Metabolic Rate
NCT02092649 ·Status: COMPLETED ·Phase: NA
-
Effects of Fish Oils on Inflammation and Insulin Resistance
NCT00579436 ·Status: COMPLETED ·Phase: NA
-
Effects of Omega-3 Fatty Acids on Bone and Frailty
NCT00634686 ·Status: UNKNOWN ·Phase: PHASE4
-
Omega-3 Fatty Acid Supplementation to Enhance Performance
NCT05924139 ·Status: COMPLETED ·Phase: NA
-
Fish Oil and Cardiovascular Suboptimal Health
NCT02103517 ·Status: COMPLETED ·Phase: PHASE3
-
The Effects of Omega-3 Fatty Acids on Aspirin Resistance
NCT00771914 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
SPM Regulation by Fish Oil Supplements in Healthy Volunteers
NCT03347006 ·Status: COMPLETED ·Phase: NA
-
Weight Loss Plus Omega-3 Fatty Acids or Placebo in High Risk Women
NCT02101970 ·Status: COMPLETED ·Phase: NA
-
Time Course Change in Skeletal Muscle and Blood Phospholipid Composition With Omega-3 Fatty Acid Supplementation
NCT05971147 ·Status: COMPLETED ·Phase: NA
-
A Ph1 Study in Healthy Male Japanese and Caucasian After Single and Multiple Doses of D5884(Omega-3-carboxylic Acids)
NCT02209766 ·Status: COMPLETED ·Phase: PHASE1